T Mary Szela

Affiliations

  • Ceo And President at Trisalus Life Sciences Inc. (TLSI), 2024-09-13
  • at Omega Therapeutics Inc. (OMGA), 2024-06-21
  • at Kura Oncology Inc. (KURA), 2024-06-07
  • Director at Prometheus Biosciences Inc. (RXDX), 2023-06-16
  • Director at Coherus Biosciences Inc. (CHRS), 2021-01-13
  • Director at Alimera Sciences Inc (ALIM), 2020-06-22
  • Chief Executive Officer at Novelion Therapeutics Inc. (NVLN), 2017-05-11
  • Chief Executive Officer at Aegerion Pharmaceuticals Inc. (AEGR), 2016-12-01
  • Director at Receptos Inc. (RCPT), 2015-08-27
  • Senior Vice President at Abbott Laboratories (ABT), 2011-12-16
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
TLSI $5.00 6,000 384,677 2024-09-13 Filing
TLSI $4.83 1,295 378,677 2024-09-13 Filing
TLSI $5.20 7,520 377,382 2024-09-12 Filing
TLSI $4.97 5,000 369,862 2024-09-10 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
CHRS $17.58 54,997 Director 0 2020-06-22 Filing
ABT $54.46 500 Officer 119,342 2011-12-14 Filing
ABT $54.45 2,781 Officer 119,842 2011-12-14 Filing
ABT $54.44 3,200 Officer 122,623 2011-12-14 Filing
ABT $54.43 2,700 Officer 125,823 2011-12-14 Filing